M.D., Ph.D., Chief Medical Officer, Genome Medical
Biography
Dr. Bleyl has served as CMO at Genome Medical since January of 2017 guiding development of the organization’s clinical care processes in its vision to bring genomics to everyday care. Dr. Bleyl is a board-certified in medical genetics with a doctorate degree in human genetics and his background spans experience in molecular biology, experimental embryology, clinical care and administrative oversight of clinical services across an integrated health system. He maintains an academic affiliation as an adjunct Associate Professor at the University of Utah where his clinical practice focuses on cardiovascular genetics with a pediatric emphasis. Prior to this role he directed the Clinical Genetics Institute (CGI) for Intermountain Healthcare where he oversaw provision of genetic services, implementation of rapid exome sequencing in neonates, deployment of a Genetic Testing Stewardship Program and development of a system-wide infrastructure for storage and use of genomic data.
Session Abstract – PMWC 2022 Silicon Valley
Track Chair:
Ed Esplin, Invitae
Genetic testing has evolved over time and various applications have successfully made it into the clinical setting. While oncology applications are dominating, we also see a rise in genetic/genomic applications for reproductive health, CVD diagnosis, or early life understanding. Technological advancements are required to scale genetic testing applications delivery including relay of genomic information to clinicians and patients. In parallel to technological challenges, hurdles are also observed when it comes to insight/knowledge extraction, reporting of clinical findings, and scaling of genetic counseling. This track will touch upon these various aspects including successful precision medicine models through biopharma ventures for rare disease understanding and direct to consumer genetic testing.
Sessions:
- Intro to Genetic Testing Applications
- Ed Esplin, Invitae - The Path to Universal Newborn Sequencing and Disease Prevention
- Robert C Green, Harvard - Evolving Paradigms in Genetic Testing Initiated by Consumers
- Paldeep S. Atwal, Everly Health - Models of Successful Precision Medicine through Biopharma Ventures in Rare Disease
- Daniel Anderson, Invitae
- Karen Miga, UCSC - Pairing Somatic Cancer Testing with Germline Testing
- Ed Esplin, Invitae - Scalable Approaches to Relaying Genomic Information to Clinicians and their Patients
- Steven Bleyl, Genome Medical
- Cassie Hajek, Sanford Imagenetics - Lessons Learned from Virtual Genetic Counseling
- Peter Hulick , NorthShore - Sharing Insights On Reimbursement
- Ashley Arthur, GeneDx
